Project Grant HT94252510040
Award Date
1/15/25
Completion Date
1/14/27
Dollars Obligated
$440K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Houston, TX 77030, USA
Similar Awards
This $1,543,430 federal Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research to target thromboinflammation in rheumatoid arthritis. The award was made to Baylor College of Medicine, a leading academic medical center in Houston, Texas, on May 15, 2024, with a period of performance through May 14, 2028. The grant enables Baylor to conduct innovative biomedical research focused on improving health outcomes...
The Department of the Army Medical Command awarded Baylor College of Medicine a $320,000 project grant under the Military Medical Research and Development program (CFDA 12.420) for the period of March 1, 2022 through February 29, 2024. The grant will support research into the anti-fibrotic effects of macropinocytosis inhibition in idiopathic pulmonary fibrosis. Through the Military Medical Research and Development program, the Department of the Army aims to transform military and public health...
The U.S. Defense Health Agency awarded Baylor College of Medicine a $896,645.00 Project Grant on May 15, 2024 under the Military Medical Research and Development program (CFDA 12.420). This grant supports research to investigate thromboinflammation in rheumatoid arthritis, with a performance period from May 2024 to May 2028. As part of this project, Baylor College of Medicine has provided $28,061 in sub-grant funding to the University of Houston System to construct and characterize wild-type and...
This $1,200,000.00 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award will fund Baylor College of Medicine to conduct research on precision glycocalyx editing of the metastatic bone microenvironment over a three-year period from September 15, 2023 to September 14, 2026. As a private non-profit university, Baylor College of Medicine has extensive experience managing federal grants and contracts for biomedical...
This Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $406,776.00 to Baylor University to develop a novel graft-localized drug delivery platform for reducing innate inflammation and optimizing immunosuppression in vascularized composite allotransplantation. The 2-year project, spanning September 2024 to September 2026, aims to advance innovative biomedical research solutions to improve health outcomes for...
The Baylor College of Medicine will research the role of the key paligenosis gene IFRD1 in gastric carcinogenesis under a $639,998 project grant award from the Department of the Army Medical Command. The award is part of the Military Medical Research and Development program administered by the agency under Assistance Listing Number 12.420. Through this three-year project grant completing in May 2025, Baylor College of Medicine will investigate medical solutions for the battlefield by...
This $1,600,000.00 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research at Baylor College of Medicine focused on developing new synthetic lethal combination therapies targeting TopBP1 and the arachidonic acid pathway for breast cancer treatment. The three-year award, with an end date of February 28, 2027, will fund basic, translational, and clinical research aimed at advancing scientific understanding and...
The federal Project Grant award of $1,597,224.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program to support the research project "BCL-XL IN BREAST CANCER METASTASIS AND THERAPY" at Baylor College of Medicine in Houston, Texas. The award, with a performance period from August 1, 2024 to July 31, 2027, will fund advanced biomedical research initiatives focused on transforming healthcare for military service...
Baylor College of Medicine was awarded a $3.67 million Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The four-year award will support research investigating KCA1.1 ion channels in synovial fibroblasts. Through this funding, Baylor College of Medicine researchers aim to advance understanding of medical solutions for battlefield injuries and transform military and public health care. The place of performance for this work...
The Department of the Army Medical Command awarded Baylor College of Medicine a $10,087,552 project grant from the Military Medical Research and Development program (CFDA 12.420) for the period of July 1, 2022 to June 30, 2026. The grant funds research on combinatorial helper-dependent adenoviral gene therapy for post-traumatic osteoarthritis. Specifically, Baylor College of Medicine and sub-awardees Cornell University ($401,517 each) will conduct preclinical studies to assess the prevention...